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Abstract For the purposes of this study, hydroxyapatite
(HA)–Al2O3–TiO2 nanobiomaterial with significant sur-
face properties and biocompatibility capable of forming
surface apatite was fabricated by cold-press and sintering
method. Samples were examined for hardness and porosity.
The results showed that in terms of hardness and porosity,
sample A (50 wt% TiO2–30 wt% HA–20 wt% Al2O3) was
superior to sample B (30 wt% TiO2–50 wt% HA–20 wt%
Al2O3), and also the density of nanobiomaterial was close
to natural bone density. Bioactivity of the samples in a
simulated body fluid (SBF) was investigated. Then, after
immersing the samples in SBF solution for a period of
7 days, sample B exhibited greater ability to form calcium
phosphate compounds on the surface as compared to
sample A. In addition, in vitro studies showed that MG-67
osteoblast-like cells attached and spread on the samples
surface. The results showed that cells proliferated in greater
numbers on the sample B as compared to the sample A.
Finally, X-ray diffraction, scanning electron microscopy,
and energy-dispersive X-ray analysis were performed to
identify phases, study microstructure, and determine per-
centage of elements, respectively. The results revealed that
considering their different properties, both nanobiomateri-
als can be used in medical applications.
Keywords Nanobiomaterial  Sintering 
Hydroxyapatite  Titania  Bioactivity  Cells proliferate
Introduction
Development of new biomaterials for medical applications
is of primary concern to researchers. Orthopedics is one of
those sciences that typically requires such materials for
healing and replacing missing parts (Aubry et al. 2009;
Dorozhkin 2010; Murugan and Ramakrishna 2005; Seal
et al. 2001; Bellucci et al. 2011; Ashokkumar and Sange-
etha 2013). Today, various synthetic materials including
composites as a bone substitute have been developed to
overcome problems associated with bone defect repair (Lee
and Shin 2007; Sivakumar and Panduranga Rao 2002;
Uemura et al. 2003; Yoneda et al. 2005; Nezafati et al.
2013). Bone is a natural composite whose mineral part is
formed by hydroxyapatite (HA) and is reinforced by col-
lagen (Olszta et al. 2007; Sun et al. 2011; Ngiam et al. 2009;
Nandakumar et al. 2013; Andiappan et al. 2013). In many
fractures and bone defects, substitute materials or fillers are
required to repair bone tissue. A material with chemical and
mechanical properties as bone cannot singularly be found,
thus, biomedical composites are often designed to provide
good biocompatibility and mechanical behavior (Chen et al.
2004; Scholz et al. 2011; Cao et al. 2011; Rath et al. 2012).
HA is a biocompatible ceramic used in orthopedic and
dental implant applications with very similar chemical
compositions to the mineral part of bone and tooth and can
establish a good bond with bone tissue. However, appli-
cation of HA due to low toughness and weak bending
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strength is limited under loading conditions (Rezwan et al.
2006; Swetha et al. 2010; Zhou and Lee 2011; Balani et al.
2007; Abdal-hay et al. 2013). Therefore, it is used as filler
in small bone defects and as a coating on metal implants
such as titanium (Bai et al. 2010a; Sadat-Shojai et al. 2010;
Sato et al. 2006). Recent studies have reported improved
ossification process and implant fixation through various
methods including plasma spray and laser (Roy et al. 2011;
Topic´ et al. 2006; Khosroshahi et al. 2009, 2007).
Today, production of HA nanocomposite has made
design of new materials with bone-like structures possible.
Such new materials create high chemical homogeneity of
coatings and allow production of dense composites at low
sinter temperatures (Aminzare et al. 2013; Andronescu
1993). Also, bioactive composites can be attached to bone
with formation of HA layer on the surface. According to
recent reports, HA-based composites with reinforcements
such as CNT, TiO2, ZrO2, Al2O3 to improve mechanical
properties have attracted the interest of researchers (Bai
et al. 2010b; Kalmodia et al. 2010; Kratschmer and
Aneziris 2011; Wen et al. 2007; Sopyan et al. 2012).
The Al2O3 bio-ceramic (alumina) increases fracture
toughness and wear resistance, while maintaining bio-
compatibility due to its inert nature. It is also able to
considerably increase thermal resistance of composites
(Kalmodia et al. 2010).
Titania (TiO2) is another common reinforcement for
composites. While being biocompatible, antibacterial, and
photo-catalyst, the presence of this bio-ceramic enhances
corrosion resistance of implants (Cho et al. 2008). Also, it is
able to absorb H2O and form titanium hydroxide (Ti–OH)
groups on the surface, which is a factor in formation of
apatite in simulated body fluid (SBF) (Beherei et al. 2009).
There are reports of fabrication of Al2O3/TiO2 (Habibpanah
et al. 2011), HA/TiO2 (Enayati-Jazi et al. 2012), HA/Al2O3
(Viswanath and Ravishankar 2006) composites for medical
applications. However, there are no reports of fabrication
HA–TiO2–Al2O3 nanobiomaterial by cold-press and sinter-
ing method. Thus, in this study, two HA–TiO2–Al2O3 nan-
obiomaterials with different weight percentage of
ingredients fabricated by cold press and sintering method.
Finally, the biocompatibility and surface properties of both
nanobiomaterials compared for medical applications.
Materials and methods
Preparation of nanobiomaterials
To synthesize the nanobiomaterial, a 2-cm wide cylindrical
steel mold was prepared to cold press the raw materials.
Then, rutile-TiO2 (20 nm), alpha-Al2O3 (80 nm), and HA
(1 lm) powders as biomaterial ingredients, and sodium
silicate for improving adhesion between particles were
purchased from the Merck Company. Two samples with
different mounts of powders were made (Table 1). In
sample A, titania (50 wt%), HA (30 wt%) and alumina (20
wt%) were mixed. HA and alumina particles are as rein-
forcement materials in sample A. In sample B, HA (50
wt%), titania (30 wt%) and alumina (20 wt%) were mixed
in which titania and alumina nanoparticles are as rein-
forcement materials.
To synthesis nanobiomaterial, different weight percent-
ages of the powders (Table 1) were mixed with sodium
silicate and for more homogeneity, powder mixtures were
milled in a polymeric ball mill at the speed of 400 rpm.
Then 4 g of the mixture was poured into the steel mold and
compressed with a uniaxial cold press at a pressure of
150 kg/cm2 (14.7 MPa). Next, the samples were dried in an
oven at 150 C for 2 h. To increase the strength, samples
were sintered at 1,000 C for 40 min, and allowed to cool
down at the oven temperature. The hardness of samples was
measured and compared before and after sintering.
Morphology and microstructure
The surface morphology and elemental map of the samples
were examined with scanning electron microscope (SEM,
VEGA II, and Tescan, USA). Images were taken of the
horizontal cross-section of samples before and after
immersion in SBF, at different magnifications. To analyze
percentage of elements in samples was used energy-dis-
persive X-ray analysis (EDAX). Also, bulk density and
apparent porosity of sintered samples were measured using
Archimedes’ method by immersing samples in water (Wan
et al. 2008).
Surface hardness
To measure surface hardness of the samples in Vickers, a
square-based pyramid with 136 angle between the oppo-
site faces was used as punch. The Vickers hardness number
(VHN) is defined as load divided by area of depression. In
practice, this area is calculated from microscopic quantities




Where, P is applied load in grams, L is average diagonal
size of indentation in mm and H is angle between opposite
Table 1 The weight percentages of materials of nanobiomaterials
Sample Al2O3 (wt%) TiO2 (wt%) HA (wt%)
A 20 50 30
B 20 30 50
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faces of diamond indenter. To find the surface hardness,
samples were placed under the Vickers punch, and a load
of 200 gf with dwell time of 10 s was applied.
In vitro bioactivity studies
To evaluate the in vitro bioactive behavior of the sam-
ples, the SBF solution was prepared in accordance with
Kokubo Instruction (Kokubo et al. 1999). SBF com-
pounds similar to human blood plasma are presented in
Table 2. After sintering the samples, they were immersed
in 60 ml of SBF and then incubated for a period of
7 days at body temperature (37 C) with 98 % humidity
and 5 % CO2. Each day, the SBF solution on the sam-
ples was replaced with a fresh solution. At the end of the
experiment, percentage of elements and surface mor-
phology of samples were evaluated by EDXA analysis
and SEM microscope.
X-ray diffraction analysis
The X-ray diffraction pattern test (XRD) (Philips, X’ Pert
Pro) was performed to identify the phases formed in
samples, and to examine their crystallization rates. The
phases in samples were evaluated by means of the Pana-
lytical Software X’ Pert High score Plus and database PDF-
2 (David et al. 2007).
In vitro cell culture
The in vitro cytotoxicity behavior of samples was evalu-
ated and compared for a minimum incubation period of
3 days using the human MG-67 osteoblast-like cells
(osteosarcoma cell line, ATCC, Invitrogen, Carlsbad CA
USA). All samples were sterilized by autoclaving at
121 C for 20 min prior to the cell culture experiment.
Following this, cells were seeded onto surface of samples
and a negative control (i.e., MG-67cells only in the cell
culture medium) then placed in a 24-well tissue culture
polystyrene (TPS). The initial cell density was 3.0 9 104
cells wall-1. One milliliter of Dulbecco’s modified Eagle’s
medium (DMEM) enriched with 10 % fetal bovine serum
was added to each well. Based on ATCC’s MG-67cell
culture protocol, cultures were maintained at 34 C under
an atmosphere of 5 % CO2 and 95 % air for up to 3 days
for cell attachment. The culture media were changed every
alternate day (Kim et al. 2004).
Cell morphology
Cell morphology was assessed after 3 days of incubation
period by SEM. Cultured samples for SEM observation
were rinsed with 0.1 M phosphate-buffered saline (PBS)
and fixed with 2 % paraformaldehyde/2 % glutaraldehyde
in 0.1 M cacodylate buffer overnight at 4 C. Following
this, post-fixation was performed for each sample with 2 %
osmium tetroxide (OsO4) for 2 h at room temperature.
Fixed samples were then dehydrated in an ethanol series
(60, 70, 80, 90 and 100 % three times), followed by a
hexamethyldisilane (HMDS) drying procedure. Dried
samples were then mounted on aluminum stubs, gold
coated and observed by SEM (Kim et al. 2004).
Cell proliferation using the MTT assay
The proliferation of viable MG-67cells attached on A and
B sample surfaces was assessed by the MTT assay (Sigma,
MO, USA) after 3 days of incubation. A 5 mg ml-1 solu-
tion of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium] was prepared by dissolving MTT in PBS and
filter sterilizing it. MTT solution was diluted (100 ll into
900 ll) with DMEM culture medium enriched with 10 %
fetal bovine and added to each sample to form formazan
through the action of mitochondrial dehydrogenases. After
2 h incubation at 34 C, samples were transferred to a new
24-well plate and 1 ml of solubilization solution made up
of 10 % Triton X-100, 0.1 N HCl and isopropanol was
added to dissolve the formazan crystals. Then 100 ll of the
resulting supernatant was transferred into a 96-well plate
and three data points were obtained from each sample. The
optical density of the solution in each well was measured at
a wavelength of 570 nm using a microplate reader (Bio-
Tek, Elx808, USA) (Huang et al. 2011).
Results and discussion
Morphology and apparent porosity
Microstructure and morphology of the surface of samples
A and B were assessed by observation of SEM images. The
SEM images (Fig. 1) show that the surface of both types of
samples is fully sintered, which is indicative of well-bon-
ded particles and correct density and porosity of the sam-
ples. However, the particle size varies after sintering and
Table 2 SBF and human blood
plasma ion concentrations
(mmol/L)
Ion Na? K? Ca2? Mg2? HCO3- Cl- HPO4
2- SO4
2-
SBF 142 0.5 2.5 1.5 4.2 147.8 1 0.5
Blood plasma 142 0.5 2.5 1.5 27 103 1 0.5
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average of pore size in the surface of samples A and B is
between 100 and 300 nm. The difference in thermal
expansion coefficient of the composite ingredients during
heating and cooling can lead to formation of micro-cracks
(Kwok et al. 2009). In this study, to prevent formation of
these cracks, samples were sintered at 1,000 C for 40 min.
As can be seen in Fig. 1, there are no cracks on the surface
of the samples. Table 3 shows the chemical composition of
nanobiomaterials.
The result of samples combination can also be visual-
ized giving a map of elements of particles under the
microscope. A homogeneous distribution of nanobiomate-
rial ingredients (P, Ca, Ti, Al) in structure of all samples is
shown in Fig. 2. The percentage porosity and density of the
samples are presented in Table 4. Sample B had a better
particle size distribution, smoother surface, and less
porosity (31.3 %) than sample A (41.99 %). An increase in
weight percentage of the nano-sized TiO2 compared to the
micron-sized HA in nanobiomaterial A amplifies the like-
lihood of a porous surface (Harle et al. 2006). Conse-
quently, with increased percentage of porosity in sample A,
vacant space is provided for growth and nutrition of bone
cells. But, with reduced HA, the bioactive and osteocon-
ductive properties of this implant were decreased. Samples
A and B have densities of 1.994 and 2.016 g/cm3,
respectively, which are very close to the bone density
(1.85 g/cm3). Of course, density of sample A compared to
sample B has decreased due to the use of nano-sized TiO2.
Use of HA particles as matrix and addition of titania (30
wt%) and alumina (20 wt%) nanoparticles as reinforcing
phase in sample B have improved bioactivity of implant in
areas where better osteogenesis and stability of implant and
more adhesion of nanobiomaterial to the bone are needed.
X-ray diffraction pattern
The X-ray diffraction patterns of A and B samples before
immersion in SBF solution can be observed in Fig. 3.
Peaks associated with HA are detected with intensity near
2H = 26 and 2H = 32 in (201) and (211) planes,
respectively. Also, b-TCP peak can be observed around
2H = 31.5 in (221) plane, which is very close to HA
peak. The TiO2 peak with a high intensity is observed near
2H = 36 in (110) crystal plane. Another reinforcement in
nanobiomaterial is alumina that can be seen near 2H = 38
and 2H = 58 in (110) and (116) planes. But Al2O3 has a
bigger peak at 2H = 35.5 that is integrated with Titania
peak at 2H = 36. The diffraction pattern peak intensity of
the TiO2 is higher in sample A. It can be seen from the
results that after sintering nanobiomaterial for 40 min at
1,000 C, the nanobiomaterial ingredients maintained their
nature, and b-TCP peak with a low intensity is observed in
the samples. The intensity of b-TCP peak was higher in
sample B due to higher percentage of HA. Also, there was
not any peak around 2H = 30 thus, calcium aluminate
phase was not observed.
Although HA is constant and stable in the body, the
presence of secondary phases causes it to dissolve, which
consequently leads to degeneration of the implant in body.
Thus, increased sintering temperature followed by higher
crystallization is necessary for longer life of the implant.
Furthermore, sintering temperatures higher than 800 C
Fig. 1 SEM images a sample
A, b sample B before immersion
in SBF
Table 3 EDAX results of nanobiomaterials before immersion in SBF
Sample Ca (%) Ti (%) O2 (%) P (%) Al (%)
A 7.76 26.53 53.77 4.45 7.49
B 13.43 18.91 53.38 7.1 7.18
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lead to decomposition of HA to b-TCP and a-TCP, whose
presence in the sample reduces biocompatibility of the
implant. Also, when samples are placed in biological
environments like blood plasma, b-TCP becomes unstable
and gradually degenerates. Thus, the presence of this phase
could be considered responsible for the composite strength
loss after exposure in SBF solution (Kwok et al. 2009).
However, in this study, due to sintering temperature
(1,000 C), the intensity of b-TCP peak was low in the
structure of both samples, but this weak peak cannot much
affect biocompatibility of the samples. During high tem-
perature processes (1,200–1,400 C) in synthesis of nano-
material, due to increased surface and reaction area, new
phases such as calcium aluminates are created that reduce
mechanical properties of the material (Viswanath and
Ravishankar 2006). In this study, to prevent formation of
secondary phases such as calcium aluminate phase, sin-
tering operations were conducted at 1,000 C.
In vitro bioactivity evaluation
The in vitro bioactive behavior and formation of calcium
phosphate phase on the surface of nanobiomaterial in SBF
solution were evaluated by SEM images and EDXA ana-
lysis. Figure 4 shows SEM images of A and B samples
Fig. 2 Elemental map a sample
A, b sample B
Fig. 3 X-ray diffraction pattern of nanobiomaterial a sample A,
b sample B before immersion in SBF
Fig. 4 SEM images a sample A, b sample B after immersion in SBF
Table 4 Percentage porosity
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after immersion in SBF solution, and formation of apatite
can be observed on both of surfaces. But, there is a con-
siderable difference in ability to form apatite in sample B
compared to A. The higher percentage of HA and TiO2
nanoparticles present in sample B is due to full coverage of
its surface by apatite, while in sample A, apatite is scat-
tered in different areas of surface. Researchers have
recently reported (Kong et al. 2006) that the increase in HA
in composites encourages the formation of apatite on the
surface of samples in SBF solution.
The biological activity of bioceramics is due to their
ability to promote the formation of HA in physiological
environments (SBF) (Fujibayashi et al. 2003; Ra´mila and
Vallet-Regi´ 2001). In this study, formation of apatite and
calcium phosphates on ceramic nanobiomaterial was
assessed and the relationship between apatite formation
and bioactivity of nanobiomaterial was identified. It can be
seen from EDAX analysis (Table 5) that calcium and
phosphorus levels significantly increased after 7 days
immersion of samples in SBF compared to their levels
before immersion (Table 3). Also, the percentages of Ti,
O2 and Al decreased with formation of an apatite-like
material on the nanobiomaterial surface. The ratio of cal-
cium to phosphorus is almost 1.7 and this ratio did not
change much in the samples after immersion in SBF.
Calcium ion concentration is controlled by the formation of
apatite layer in SBF and its release from the samples
(Martı´nez et al. 2000).
Surface hardness and reasons for fabrication
of nanobiomaterial with 3 materials
Table 6 presents the results of the surface hardness before
and after sintering operation. The surface hardness of both
A and B samples nearly doubled after sintering. Obviously,
this increase in surface hardness was due to sintering.
However, non-homogeneous distribution of powders in
nanobiomaterial structures could cause a reduction in
hardness and strength of the samples. The surface hardness
of sample B before and after sintering was almost half that
of sample A, and since the amount of Al2O3 was constant
in both of samples; this may have been due to reduction in
the amount of TiO2 in sample B. Another reason for
reduced hardness in sample B compared to sample A could
be higher formation of beta-tri-calcium phosphate phase in
sample B because of increasing in the amount of HA.
HA is widely used as a biomaterial in medical applica-
tions, and alone can amplify bioactivity and tendency to
absorb biological materials like protein but, when HA coats
on titanium substrate, mechanical properties (fracture
toughness) and adhesion strength are weak. Research shows
that the presence of TiO2 alongside HA in composite and
HA coating on Ti surface causes increased adhesion
strength and corrosion resistance (Wen et al. 2007). In
addition, it can elevate surface hardness without compro-
mising formation of apatite. The presence of Al2O3 in the
sample does not affect calcinations process (Li et al. 1995).
Besides, addition of 20 % Al2O3 almost doubled fracture
toughness and HA strength (Viswanath and Ravishankar
2006). As reinforcement in composites, TiO2 is able to
absorb H2O and form Ti–OH groups on the surface, which
eventually leads to the formation of apatite in SBF solution
and enhances bioactivity of samples (Madhan Kumar and
Rajendran 2013). Therefore, this reinforcement material has
an important role in adhesion of implant to the bone (Be-
herei et al. 2009).Particle size and distribution of ingredi-
ents in composites affect their strengths. Thus, in this study,
3-phase ceramic HA–TiO2–Al2O3 was fabricated.
In vitro behavior of nanobiomaterials
SEM observation revealed the MG-67cell attachment,
growth and spreading on different sample surfaces. Fig-
ure 5 shows the morphologies of the cells on samples after
3 days of culture. Cells were flattened and well spread
across the A and B sample surfaces after 3 days. On both
the A and B sample surfaces, cells were seen to adhere to
each other with cellular micro-extensions (e.g., filopodia),
and were connected to the substrate in addition to neigh-
boring cells. Cells were also found to have migrated into
the pores and were observed to bridge them. However, on
the A surface, relatively fewer cells were observed
(Fig. 6a), but on the B sample, as is shown in the high-
magnification SEM image in Fig. 6b, cells were observed
to grow into the pores. On the B surface cell numbers were
increased, and the entire sample surface was covered with
cells having numerous filopodia extensions attached to the
surface irregularities, as shown in Fig. 5b.
After 3 days of culture, cells appeared to be more
elongated and confluent on B, as shown in Fig. 6b. Evi-
dently, granules were deposited on the cell surfaces
Table 5 EDXA results of nanobiomaterials after 7 days immersion
in SBF
Sample Ca (%) Ti (%) O2 (%) P (%) Al (%)
A 18.26 20.75 47.61 9.74 3.64
B 25.6 8.33 49.26 14.62 2.19
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because of extracellular matrix (ECM) mineralization. In
contrast, on sample A, cells never reached complete con-
fluence over the entire sample surface because of the higher
pore volume. As shown in Fig. 6, on both of samples, cells
formed multilayer clusters (i.e., Cells appeared cuboidal
and had a three-dimensional morphology with more filo-
podia) on the smooth surface area. Also, nano-scale grains
and high volume fraction of grain boundaries in HA
nanomaterial can increase adhesion of osteoblasts, cell
proliferation, and mineralization of these composites
(Zhang and Kwok 2011).
The MTT assay was used to quantitatively determine the
proliferation of viable MG-67cells on the A and B sample
surfaces. Figure 7 shows a comparison of viable cell
densities for samples with negative control after 3 days of
culture. For culture durations, cells proliferated in greater
numbers on the sample B compared to the sample A. It was
observed that, cells proliferated most rapidly on the sam-
ples with the highest porosity, i.e., on B in comparison to A
sample. Therefore, the results revealed that both nanobi-
omaterials can be used in different medical applications.
Conclusions
In this study, nanobiomaterial HA–TiO2–Al2O3 was fab-
ricated with cold-press and sintering method, and with
desired surface properties. The bioactivity and formation of
Fig. 5 SEM micrographs
illustrating MG-67cell
morphology after 3 days of
culture on a sample A, and
b sample B
Fig. 6 high-magnification SEM
micrographs illustrating MG-
67cell morphology after 3 days
of culture on a sample A, and
b sample B
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calcium phosphate phase on the surface nanobiomaterial in
SBF solution were investigated. On the surface of sample B
with higher weight percentage of HA, more apatite and
calcium phosphate phases were formed as compared to
sample A. Also, density of the nanobiomaterial was near
that of natural bone. The surface hardness increased after
sintering in both samples, while surface hardness of sample
A with higher weight percentage of TiO2 before and after
sintering was more than that in sample B. Creation of a
surface without micro-cracks, reduction in creation of b-
TCP phase, and prevention of formation of a-Ca3 (PO4)2
phase were other results achieved in this study. In addition,
on both of the A and B sample surfaces, cells were seen to
adhere to each other with cellular micro-extensions but on
the B surface cell numbers were increased, and the entire
sample surface was covered with cells. Therefore, given
the different properties of the nanobiomaterial fabricated,
both can be used in different orthopedics and dental
implant applications. Sample B can be used to improve
implant bioactivity in areas that need improved osteogen-
esis, fixation of bone implant and bone filling, and
increased adhesion of nanobiomaterial to the bone.
Meanwhile, sample A can be used in areas that need
coating to increase biocompatibility, increased adhesion,
and implant strength.
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